Matthew Farrer, PhD, Imperial College

Neurogenetics and Translational Medicine University of British Columbia, Vancouver, Vancouver, BC, Canada 
Neurodegenerative diseases
"Matthew Farrer"
Cross-listing: Neurotree


Sign in to add trainee
Igor Tatarnikov grad student 2015- UBC (FlyTree)
Stefano Cataldi grad student 2014-2018 UBC (FlyTree)
Bahareh Behrouz post-doc 2008-2010 Mayo Clinic Jacksonville (Neurotree)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Lai D, Alipanahi B, Fontanillas P, et al. (2021) Genome-wide association studies of LRRK2 modifiers of Parkinson's disease. Annals of Neurology
Bentley SR, Guella I, Sherman HE, et al. (2021) Hunting for Familial Parkinson's Disease Mutations in the Post Genome Era. Genes. 12
Lin CH, Farrer MJ, Wu RM. (2021) Reply: UQCRC1 variants in Parkinson's disease: a large cohort study in the Chinese mainland. Brain : a Journal of Neurology
Kuhlmann N, Wagner Valladolid M, Quesada-Ramírez L, et al. (2021) Chronic and Acute Manipulation of Cortical Glutamate Transmission Induces Structural and Synaptic Changes in Co-cultured Striatal Neurons. Frontiers in Cellular Neuroscience. 15: 569031
Bu M, Farrer MJ, Khoshbouei H. (2021) Dynamic control of the dopamine transporter in neurotransmission and homeostasis. Npj Parkinson's Disease. 7: 22
Follett J, Farrer MJ. (2021) LRRK2; a dynamic regulator of cellular trafficking. Brain Research. 1761: 147394
Robert J, Weilinger NL, Cao LP, et al. (2020) An in vitro bioengineered model of the human arterial neurovascular unit to study neurodegenerative diseases. Molecular Neurodegeneration. 15: 70
Lin CH, Tsai PI, Lin HY, et al. (2020) Mitochondrial UQCRC1 mutations cause autosomal dominant parkinsonism with polyneuropathy. Brain : a Journal of Neurology
Lüth T, König IR, Grünewald A, et al. (2020) Age at Onset of LRRK2 p.Gly2019Ser Is Related to Environmental and Lifestyle Factors. Movement Disorders : Official Journal of the Movement Disorder Society
Brown EE, Blauwendraat C, Trinh J, et al. (2020) Analysis of DNM3 and VAMP4 as genetic modifiers of LRRK2 Parkinson's disease. Neurobiology of Aging
See more...